3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
7
Breast Neoplasms
4
Urothelial Cancer
2
Urinary Bladder Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasm Metastasis
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer
1
Non Small Cell Lung Cancer NSCLC
1
Nasopharyngeal Carcinoma
1
Metastatic Urothelial Cancer
1
Metastatic Adenocarcinoma of the Pancreas
1
Gallbladder Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma
1
Bile Duct Neoplasms
1
Interventions
Rituximab
3
acalabrutinib
2
Bendamustine Hydrochloride
2
zanubrutinib
1
venetoclax
1
umbralisib
1
ublituximab
1
pirtobrutinib
1
fludarabine
1
brexucabtagene autoleucel
1
axicabtagene ciloleucel
1
Lenalidomide
1
Cyclophosphamide
1
Appointments and Schedules
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Lymphoma, Mantle-Cell
×
Gemcitabine
×
Clear all
No trials found.